FDA Commissioner raises concern over purchase of CBD services and products
Outgoing U.S. Food and Drug Administration (Food And Drug Administration) Commissioner Scott Gottlieb indicated concern about the country’s leading drugstore chains attempting to sell CBD services and products.
Walgreens has recently established which they shall start offering CBD-infused aerosols, ointments, balms, and patches in around 1,500 stores throughout nine states where medical cannabis is currently appropriate. Rival drugstore CVS Pharmacy, meanwhile, has introduced CBD topicals in around 800 shops across eight states.
Throughout a House Appropriations Committee hearing on Wednesday, Gottlieb raised concern about Walgreens and CVS stepping to the cannabis market.
Worldwide CBD Exchange
“So you see big-box stores trying to promote CBD products for many uses in which the claims seem to be possibly throughout the line, to treat discomfort, for instance,” he said.
FDA sets May 31 public hearing on legalization of CBD in food, drinks
An additional associated news, the agency has set the initial general public hearing regarding the legalization of CBD in meals and beverages for May 31, 2019. Continue reading “FDA Commissioner raises concern over purchase of CBD services and products”